AU2010280497B2 - Anhydrate of tiotropium bromide - Google Patents

Anhydrate of tiotropium bromide Download PDF

Info

Publication number
AU2010280497B2
AU2010280497B2 AU2010280497A AU2010280497A AU2010280497B2 AU 2010280497 B2 AU2010280497 B2 AU 2010280497B2 AU 2010280497 A AU2010280497 A AU 2010280497A AU 2010280497 A AU2010280497 A AU 2010280497A AU 2010280497 B2 AU2010280497 B2 AU 2010280497B2
Authority
AU
Australia
Prior art keywords
tiotropium bromide
anhydrous tiotropium
anhydrous
organic solvent
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2010280497A
Other languages
English (en)
Other versions
AU2010280497A8 (en
AU2010280497A1 (en
Inventor
Vinayak Govind Gore
Dattatrey Kokane
Bindu Manojkumar
Dattatraya Shinde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Generics UK Ltd
Original Assignee
Generics UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Generics UK Ltd filed Critical Generics UK Ltd
Publication of AU2010280497A1 publication Critical patent/AU2010280497A1/en
Publication of AU2010280497A8 publication Critical patent/AU2010280497A8/en
Application granted granted Critical
Publication of AU2010280497B2 publication Critical patent/AU2010280497B2/en
Ceased legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • C07D451/10—Oxygen atoms acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2010280497A 2009-08-07 2010-08-06 Anhydrate of tiotropium bromide Ceased AU2010280497B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN1048KO2009 2009-08-07
IN1048/KOL/2009 2009-08-07
PCT/GB2010/051310 WO2011015882A2 (en) 2009-08-07 2010-08-06 Novel anhydrate

Publications (3)

Publication Number Publication Date
AU2010280497A1 AU2010280497A1 (en) 2012-02-23
AU2010280497A8 AU2010280497A8 (en) 2012-03-08
AU2010280497B2 true AU2010280497B2 (en) 2015-10-22

Family

ID=42830336

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2010280497A Ceased AU2010280497B2 (en) 2009-08-07 2010-08-06 Anhydrate of tiotropium bromide

Country Status (9)

Country Link
US (2) US8697719B2 (enExample)
EP (1) EP2462140A2 (enExample)
JP (2) JP5822831B2 (enExample)
CN (1) CN102639531B (enExample)
AU (1) AU2010280497B2 (enExample)
CA (2) CA2768553C (enExample)
IN (1) IN2012DN00968A (enExample)
NZ (2) NZ597920A (enExample)
WO (1) WO2011015882A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1869035E (pt) 2005-12-19 2013-01-10 Sicor Inc Novas formas de brometo de tiotrópio e processos para sua preparação
US9108962B2 (en) 2005-12-19 2015-08-18 Sicor, Inc. Forms of tiotropium bromide and processes for preparation thereof
CA2768553C (en) 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
TR201111589A2 (tr) * 2011-03-03 2012-09-21 Bi̇lgi̇ç Mahmut Tiotropyum bromür susuz kristal formu.
PT106142B (pt) 2012-02-10 2014-07-18 Hovione Farmaci Ncia S A Processo para a preparação de brometo de tiotrópio
EP2897955B1 (en) * 2012-09-11 2019-11-06 Bilgic, Mahmut New tiotropium bromide crystalline form
CN104341413A (zh) * 2013-07-29 2015-02-11 天津金耀集团有限公司 一种无水噻托溴铵的新晶型
HUE045868T2 (hu) * 2013-11-22 2020-01-28 Teva Branded Pharmaceutical Products R&D Inc Inhalálható gyógykészítmény
EP2913332A1 (en) 2014-02-27 2015-09-02 Euticals S.P.A. Crystalline form of tiotropium bromide with lactose
US10555903B2 (en) * 2016-10-14 2020-02-11 Glenmark Specialty S.A. Nebulizable compositions of tiotropium and formoterol

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
US20050143410A1 (en) * 2003-11-03 2005-06-30 Boehringer Ingelheim International Gmbh Novel crystalline anhydrate with anticholinergic efficacy
CN1861598A (zh) * 2006-03-07 2006-11-15 南昌弘益科技有限公司 噻托溴铵无水物制备方法
US20070092453A1 (en) * 2005-05-02 2007-04-26 Boehringer Ingelheim International Gmbh Novel Crystalline Forms of Tiotropium Bromide
WO2007075858A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Novel forms of tiotropium bromide and processes for preparation thereof
WO2007075838A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Pure and stable tiotropium bromide
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610163A (en) 1989-09-16 1997-03-11 Boehringer Ingelheim Gmbh Esters of thienyl carboxylic acids and amino alcohols and their quaternization products
US6908928B2 (en) 2000-10-12 2005-06-21 Bi Pharma Kg. Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
AU2002214996B2 (en) 2000-10-12 2007-03-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Crystalline monohydrate, method for producing the same and the use thereof in the production of a medicament
DE10064816A1 (de) 2000-12-22 2002-06-27 Boehringer Ingelheim Pharma Verfahren zur Herstellung eines Anticholinergikums
US6506900B1 (en) 2001-01-31 2003-01-14 Boehringer Ingelheim Pharma Ag Process for preparing a scopine ester intermediate
AUPR315301A0 (en) 2001-02-19 2001-03-15 Silverbrook Research Pty. Ltd. An Apparatus (ART102)
US6608055B2 (en) 2001-06-22 2003-08-19 Boehringer Ingelheim Pharma Kg Crystalline anticholinergic, processes for preparing it and its use for preparing a pharmaceutical composition
US6610849B2 (en) 2001-06-28 2003-08-26 Boehringer Ingelheim Pharma Kg Process for the manufacture of tropenol
DE10200943A1 (de) 2002-01-12 2003-07-24 Boehringer Ingelheim Pharma Verfahren zur Herstellung von Scopinestern
US6747153B2 (en) 2002-05-31 2004-06-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg Industrial process for preparing tropenol
ES2329133T3 (es) 2003-05-28 2009-11-23 Theravance, Inc. Compuestos azabicicloalcanicos como antagonistas de receptores de muscarinicos.
WO2005042527A1 (de) * 2003-11-03 2005-05-12 Boehringer Ingelheim International Gmbh Neues kristallines anhydrat mit anticholinerger wirksamkeit
CN1271073C (zh) * 2004-10-26 2006-08-23 江苏正大天晴药业股份有限公司 结晶性抗胆碱能药噻托溴铵晶体
WO2006076222A2 (en) 2005-01-10 2006-07-20 Glaxo Group Limited Pharmaceutical formulations
EP1879888A2 (en) * 2005-05-02 2008-01-23 Boehringer Ingelheim International GmbH Crystalline forms of tiotropium bromide
DE102005035112A1 (de) 2005-07-27 2007-02-15 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neues Verfahren zur Herstellung von Tiotropiumsalzen unter Anwendung von in organischen Lösungsmitteln löslichen N-Methylscopiniumsalzen
US20080051582A1 (en) 2006-07-10 2008-02-28 Sicor Inc. Process for the preparation of tiotropium bromide
WO2008089852A1 (de) 2007-01-26 2008-07-31 Boehringer Ingelheim Pharma Gmbh & Co.Kg Neues verfahren zur herstellung von tiotropiumsalzen
KR20150038750A (ko) 2007-02-21 2015-04-08 알미랄, 에스.에이. 신규 방법
WO2008104955A1 (en) 2007-02-28 2008-09-04 Ranbaxy Laboratories Limited Azoniatricyclo [3.3.1.0] nonane derivatives as muscarinic receptor antagonists
WO2009087419A1 (en) 2008-01-10 2009-07-16 Generics [Uk] Limited Novel process for the preparation of scopine esters
WO2011015884A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Process to prepare scopine esters
WO2011015883A1 (en) 2009-08-07 2011-02-10 Generics [Uk] Limited Dichloromethane solvate of tiotropium bromide and its use
CA2768553C (en) 2009-08-07 2016-08-02 Generics [Uk] Limited Anhydrate of tiotropium bromide
WO2011095800A2 (en) 2010-02-02 2011-08-11 Generics [Uk] Limited Analytical methods

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0418716A1 (de) * 1989-09-16 1991-03-27 Boehringer Ingelheim Kg Neue Thienylcarbonsäureester von Aminoalkoholen, ihre Quaternierungsprodukte sowie die Herstellung und Verwendung dieser Verbindungen
US20050143410A1 (en) * 2003-11-03 2005-06-30 Boehringer Ingelheim International Gmbh Novel crystalline anhydrate with anticholinergic efficacy
US20070092453A1 (en) * 2005-05-02 2007-04-26 Boehringer Ingelheim International Gmbh Novel Crystalline Forms of Tiotropium Bromide
WO2007075858A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Novel forms of tiotropium bromide and processes for preparation thereof
WO2007075838A2 (en) * 2005-12-19 2007-07-05 Sicor Inc. Pure and stable tiotropium bromide
US20070167480A1 (en) * 2005-12-19 2007-07-19 Sicor Inc. Pure and stable tiotropium bromide
CN1861598A (zh) * 2006-03-07 2006-11-15 南昌弘益科技有限公司 噻托溴铵无水物制备方法

Also Published As

Publication number Publication date
US20140249175A1 (en) 2014-09-04
WO2011015882A2 (en) 2011-02-10
AU2010280497A8 (en) 2012-03-08
CN102639531B (zh) 2016-01-20
US9181268B2 (en) 2015-11-10
CA2768553A1 (en) 2011-02-10
JP5822831B2 (ja) 2015-11-24
NZ624602A (en) 2015-11-27
NZ597920A (en) 2014-05-30
EP2462140A2 (en) 2012-06-13
JP2015214574A (ja) 2015-12-03
CN102639531A (zh) 2012-08-15
US20150051241A9 (en) 2015-02-19
JP2013501041A (ja) 2013-01-10
AU2010280497A1 (en) 2012-02-23
CA2768553C (en) 2016-08-02
IN2012DN00968A (enExample) 2015-04-10
WO2011015882A3 (en) 2011-09-01
CA2931876A1 (en) 2011-02-10
US8697719B2 (en) 2014-04-15
US20120149725A1 (en) 2012-06-14

Similar Documents

Publication Publication Date Title
CA2768553C (en) Anhydrate of tiotropium bromide
CN100586948C (zh) 结晶性抗胆碱能药,其制备方法及其在药物制备中的用途
JP5567610B2 (ja) 臭化チオトロピウムの新規な形態およびそれを製造する方法
JP5902774B2 (ja) スコピンエステルを調製するための新規プロセス
CN104797566A (zh) 沃替西汀氢溴酸盐的新结晶形式
JP2007302658A (ja) イマチニブメシレートの多形フォーム及び新規結晶フォーム及び非晶フォーム並びにフォームαの調製方法
CA2658165A1 (en) Process for the preparation of tiotropium bromide
JP2015524840A (ja) 抗ウイルス化合物の固体形態
WO2011015883A1 (en) Dichloromethane solvate of tiotropium bromide and its use
JP2013501041A5 (enExample)
KR20200030106A (ko) 빌란테롤 트리페나테이트의 신규의 결정형 및 이들의 제조방법
JP5057986B2 (ja) 有機化合物
JP2025533955A (ja) （２ｓ，５ｒ）－５－（２－クロロフェニル）－１－（２’－メトキシ－［１，１’－ビフェニル］－４－カルボニル）ピロリジン－２－カルボン酸の多形およびその調製プロセス
CN104098560A (zh) 噻托溴铵的结晶形式
JP7736311B2 (ja) ピリミジノジアゼピン誘導体の結晶性形態
JPWO2002088147A1 (ja) セフェム化合物の硫酸塩
KR20260049276A (ko) 5-((3r,55)-3-아미노-5-트리플루오로메틸-피페리딘-1-일)-퀴놀린-8-카르보니트릴반수화물의 결정형 h1
KR20160143407A (ko) 신규한 바레니클린 뮤케이트 염, 이의 결정형 및 이의 제조방법
KR20110103711A (ko) 신규 결정형의 자나미비어 수화물 및 이의 제조방법
HK1068540B (en) Crystalline anticholinergic, method for its production, and use thereof in the production of a drug
JP2014012641A (ja) 新規ピリジン誘導体

Legal Events

Date Code Title Description
TH Corrigenda

Free format text: IN VOL 26, NO 6, PAGE(S) 949 UNDER THE HEADING PCT APPLICATIONS THAT HAVE ENTERED THE NATIONAL PHASE - NAME INDEX UNDER THE NAMES MYLAN INDIA PRIVATE LIMITED; GENERICS [UK] LIMITED, APPLICATION NO. 2010280497, UNDER INID (71) REMOVE CO-APPLICANT MYLAN INDIA PRIVATE LIMITED

DA3 Amendments made section 104

Free format text: THE NATURE OF THE AMENDMENT IS: AMEND THE INVENTION TITLE TO READ ANHYDRATE OF TIOTROPIUM BROMIDE

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired